FR17C1058I1 - - Google Patents
Info
- Publication number
- FR17C1058I1 FR17C1058I1 FR17C1058C FR17C1058I1 FR 17C1058 I1 FR17C1058 I1 FR 17C1058I1 FR 17C1058 C FR17C1058 C FR 17C1058C FR 17C1058 I1 FR17C1058 I1 FR 17C1058I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46683803P | 2003-04-29 | 2003-04-29 | |
| EP07116330A EP1870096A3 (en) | 2003-04-29 | 2004-04-21 | Compositions for affecting weight loss |
| EP04760321A EP1617832B1 (en) | 2003-04-29 | 2004-04-21 | Compositions for affecting weight loss |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR17C1058I1 true FR17C1058I1 (en) | 2018-01-12 |
| FR17C1058I2 FR17C1058I2 (en) | 2019-01-11 |
Family
ID=38719840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR17C1058C Active FR17C1058I2 (en) | 2003-04-29 | 2017-12-08 | COMPOSITIONS COMPRISING AN OPIOID ANTAGONIST AND BUPROPION TO INFLUENCE WEIGHT LOSS |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1870096A3 (en) |
| BE (1) | BE2017C064I2 (en) |
| CY (2) | CY1119418T1 (en) |
| FR (1) | FR17C1058I2 (en) |
| LU (1) | LUC00054I2 (en) |
| NL (1) | NL300918I2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10576045B2 (en) | 2011-02-16 | 2020-03-03 | Nir Barak | Low dosage combinations of fluoxetine and reboxetine for treating obesity |
| US20150342946A1 (en) | 2013-01-30 | 2015-12-03 | Pharmorx Therapeutics, Inc. | Treatments For Depression And Other Diseases With A Low Dose Agent |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217353A (en) * | 1978-05-19 | 1980-08-12 | E. I. Du Pont De Nemours And Company | Method for inducing anorexia |
| WO1996009047A1 (en) * | 1994-09-19 | 1996-03-28 | The Du Pont Merck Pharmaceutical Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| EP1776955B1 (en) * | 1996-05-07 | 2012-08-15 | VeroScience LLC | Medical use and composition for the treatment of lipid and glucose metabolism disorders |
| JP2002501892A (en) * | 1998-01-29 | 2002-01-22 | セプラコア インコーポレーテッド | Pharmaceutical use of optically pure (-)-viewpropion |
| US6071918A (en) * | 1999-07-21 | 2000-06-06 | Dupont Pharmaceuticals Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| US6403657B1 (en) * | 1999-10-04 | 2002-06-11 | Martin C. Hinz | Comprehensive pharmacologic therapy for treatment of obesity |
| WO2001052851A1 (en) * | 2000-01-22 | 2001-07-26 | Albert Shulman | Methods for the treatment of substance abuse |
| DE60134251D1 (en) * | 2000-09-18 | 2008-07-10 | Sanos Bioscience As | USE OF GLP-2 PEPTIDES |
| US20030087896A1 (en) * | 2001-08-09 | 2003-05-08 | Hillel Glover | Treatment of refractory depression with an opiate antagonist and an antidepressant |
| US20040102440A1 (en) * | 2002-07-01 | 2004-05-27 | Wong Erik Ho Fong | Method of promoting smoking cessation |
| JP2005531557A (en) * | 2002-05-17 | 2005-10-20 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Use of effective compounds as selective opiate receptor modulators |
| US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
-
2004
- 2004-04-21 EP EP07116330A patent/EP1870096A3/en not_active Withdrawn
-
2017
- 2017-09-05 CY CY20171100932T patent/CY1119418T1/en unknown
- 2017-12-08 FR FR17C1058C patent/FR17C1058I2/en active Active
- 2017-12-11 NL NL300918C patent/NL300918I2/en unknown
- 2017-12-11 LU LU00054C patent/LUC00054I2/en unknown
- 2017-12-11 CY CY2017041C patent/CY2017041I2/en unknown
- 2017-12-12 BE BE2017C064C patent/BE2017C064I2/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL300918I1 (en) | 2017-12-14 |
| CY2017041I1 (en) | 2018-09-05 |
| FR17C1058I2 (en) | 2019-01-11 |
| NL300918I2 (en) | 2018-01-09 |
| EP1870096A3 (en) | 2011-04-20 |
| LUC00054I1 (en) | 2017-12-13 |
| BE2017C064I2 (en) | 2023-08-09 |
| CY1119418T1 (en) | 2018-03-07 |
| EP1870096A2 (en) | 2007-12-26 |
| CY2017041I2 (en) | 2018-09-05 |
| LUC00054I2 (en) | 2018-02-21 |